Scholarlink

Purpose of Review <p>Aging individuals are often overlooked in substance use disorder (SUD) research and interventions. This scoping review examined recent clinical trials (2014–2024) and review articles (2019–2024) focused on SUD interventions for aging populations.</p> Recent Findings <p>Three intervention trials were identified: two for alcohol, one for tobacco, and none for cannabis, opioids, or benzodiazepines. Six review articles characterized substance-specific interventions and community-based approaches. These reviews confirmed no intervention trials for cannabis and benzodiazepines, while opioid literature was limited to observational studies.</p> Summary <p>Evidence-based SUD interventions tailored to older adults remain scarce with most outcomes centered around reduction and abstinence, rarely addressing psychosocial or quality of life domains. The lack of evidence-based interventions limits informed and precise clinical decision-making. Future research should expand beyond alcohol and tobacco to develop age-specific interventions incorporating digital therapeutics and community-based approaches. Given the complex comorbidities of aging, a broader, age-specific definition of recovery is needed to guide effective care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Beyond the Golden Years: A Scoping Review of Interventions for Substance Use Disorders in Aging Adults

  • 期刊论文

  • 发表日期：

    2026年1月19日

查看全文
  • Heba D. Elnaiem,
  • Miriam Guzman,
  • Denis G. Antoine

摘要

Purpose of Review

Aging individuals are often overlooked in substance use disorder (SUD) research and interventions. This scoping review examined recent clinical trials (2014–2024) and review articles (2019–2024) focused on SUD interventions for aging populations.

Recent Findings

Three intervention trials were identified: two for alcohol, one for tobacco, and none for cannabis, opioids, or benzodiazepines. Six review articles characterized substance-specific interventions and community-based approaches. These reviews confirmed no intervention trials for cannabis and benzodiazepines, while opioid literature was limited to observational studies.

Summary

Evidence-based SUD interventions tailored to older adults remain scarce with most outcomes centered around reduction and abstinence, rarely addressing psychosocial or quality of life domains. The lack of evidence-based interventions limits informed and precise clinical decision-making. Future research should expand beyond alcohol and tobacco to develop age-specific interventions incorporating digital therapeutics and community-based approaches. Given the complex comorbidities of aging, a broader, age-specific definition of recovery is needed to guide effective care.